Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Adefovir dipivoxil shows activity against lamivudine-resistant HBV

April 20, 2000

Dainippon describes motility-enhancing activity of 5-HT4 receptor agonists

April 18, 2000

Isis Pharmaceuticals completes financing with Elan for HCV joint venture

April 18, 2000

Kosan Biosciences awarded SBIR grant to develop motilin receptor agonists

April 18, 2000

Maxamine plus IFN-alpha yields up to 69% complete response in HCV

April 17, 2000

Novel DELTA-lactones with utility in inflammatory conditions disclosed by Inflazyme

April 17, 2000

New anti-H. pylori agents from Byk Gulden particularly suitable for administration by the oral route

April 14, 2000

FDA grants priority review to Zelmac for IBS

April 14, 2000

Organoselenium compounds as antioxidants, cytoprotective agents presented by Oxis

April 13, 2000

Loss of hepatitis B antigen increases with increasing duration of lamivudine therapy

April 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...